Systemic Histopathology of Rats Treated with 6-Sulfanilamidoindazole,a Novel Arthritogenic Sulfonamide

Abstract

6-Sulfanilamidoindazole (6SAI) is a sulfonamide that induces acute, self-limiting arthritis in rats, and 6SAI-induced arthritis is thought to be a model for testing anti-inflammatory agents. In this study, in order to clarify the location of arthritis and relationships between arthritis and other changes in this model, we have investigated the detailed pathologic changes in rats administered orally with 6SAI (125, 250, 500 mg/kg) daily for 4 wk in a time-course experiment. Moderate to severe arthritis was observed in rats of middle- and high-dose groups. Histologically, in the affected ankle, exudative synovitis and periarthritis were observed at 1 wk, granulation tissue formation with angiogenesis and periosteal new bone formation at 2 wk, and marked fibrosis of affected area at 4 wk, respectively. In addition to these changes, in periarticular and periosteal tissues of affected ankles, subendothelial insudation of small-sized arteries and medial fibrinoid degeneration of medium-sized arteries were observed at 1 and 2 wk and intimal thickening and medial hypertrophy at 4 wk, respectively. No arterial changes were observed in the unaffected ankles. Similar arterial changes were often observed in the liver, thyroid glands, and lungs and rarely in various organs and tissues. Acute inflammation of serous tissues such as mesentery, mediastinum, and capsule of spleen or thymus were also present in 6SAI-treated groups, and it was sometimes accompanied by arteritis. In addition, in 6SAI-treated rats, follicular hyperplasia of thyroid glands and pituitary changes, which are thought to be related to depression of thyroid hormone production by 6SAI, were observed. These results show that 6SAI induces not only arthritis but also arteritis, serositis, and thyroid change, and it is necessary to take the interaction between these changes into consideration when anti-inflammatory agents are tested in this model.

Keywords

Subendothelial insudation medial fibrinoid degeneration intimal thickening medial hypertrophy serositis thyroid follicular hyperplasia

References

1. Boor PJ , Gotlieb AI , Joseph EC , Kerns WD , Roth RA , and Tomaszewski KE (1995). Contemporary issues in toxicology. Toxicol. Appl. Pharmacol. 132: 177–195.

2. Capen CC , DeLellis RA , and Yarrington JT (1991). Endocrine system. In: Handbook of Toxicologic Pathology, WM Haschek and CG Rousseaux (eds). Academic Press, San Diego, pp. 675–760.

3. Cole BC , Miller ML , and Ward JR (1969). The role of mycoplasma in rat arthritis induced by 6-sulfanilamidoindazole. Proc. Soc. Exp. Biol. Med. 130: 994–1000.

4. Collins JJ , Elwell M , Lamb JCIV , Manus AG , Heath JE , and Makovec GT (1988). Subchronic toxicity of orally administered (gavage and dosed-feed) theophylline in Fischer 344 rats and B6C3F1 mice. Fundam. Appl. Toxicol. 11: 472–484.

5. Gad SC (1992). The rat-pathology. In: Animal Models in Toxicology, SC Gad and CP Chengelis (eds). Marcel Dekker, New York, pp. 88–96.

6. Gopinath C (1992). Susceptibility of the cardiovascular system to toxic substances. In: Pathobiology of the Aging Rat, Vol I, U Mohr DL Dungworth , and CC Capen (eds). ILSI Press, Washington, D.C., pp. 319–327.

7. Hanton G , Net J-LL , Ruty B , and Leblanc B (1995). Characterization of the arteritis induced by infusion of rats with UK-61,260, an inodilator, for 24 h. A comparison with the arteritis induced by fenoldopam mesylate. Arch. Toxicol. 69: 698–704.

8. Haynes RC Jr and Murad F (1985). Thyroid and antithyroid drugs. In: The Pharmacological Basis of Therapeutics, AG Gilman , LS Goodman , TW Rail , and F Murad (eds). Macmillan Publishing Company, New York, pp. 1389–1411.

9. Hazama F , Ooshima A , Tanaka T , Tomimoto K , and Okamoto K (1975). Vascular lesions in the various substrains of spontaneously hypertensive rats and the effects of chronic saltingestion. Jpn. Circ. J. 39: 7–22.

10.

10. Hicks JD (1966). Vascular changes in the kidneys of NZB mice and NZBXNZW F1 hybrids. J. Pathol. Bacteriol. 91: 479–486.

11.

11. Hirschelmann R and Schade R (1986). 6-Sulphanilamidoindazole-induced arthritis in rats: Substance effects and acute-phase reaction. Int. J. Tissue React. 8: 469–473.

12.

12. Hirschelmann R , Schade R , and Bekemeier H (1980). 6-Sulphanil-amidoindazole arthritis of rats: Relation between acute-phase protein, degree of arthritis and treatment with soybean trypsin inhibitor. Agents Actions 10: 431–434.

13.

13. Jones TC and Hunt RD (1983). The musculoskeletal system. In: Veterinary Pathology, 5th ed., TC Jones and RD Hunt (eds). Lea & Febiger, Philadelphia, pp. 1180–1182.

14.

14. Joseph EC , Rees JA , and Dayan AD (1996). Mesenteric arteriopathy in the rat induced by phosphodiesterase III inhibitors: An investigation of morphological, ultrastructural, and hemodynamic changes. Toxicol. Pathol. 24: 436–450.

15.

15. Kyogoku M (1977). Studies on SL/Ni mouse, animal model of polyarteritis nodosa. In: Vascular Lesion of Collagen Disease and Related Conditions. U Shiokawa (ed). Univ. of Tokyo Press, Tokyo, pp. 356.

16.

16. Lalich JJ , Johnson WD , Raczniak TJ , and Shumaker RC (1977). Fibrin thrombosis in monocrotaline pyrrole induced cor pulmonale in rats. Arch. Pathol. Lab. Med. 101: 69–73.

17.

17. Langle UW , Bruggermann S , Prentice DE , Ettlin RA , Richardson B , Naef R , and Cordier A (1993/94). Hypertrophic osteopathy in rats following chronic administration of SDZ MNS 949, and iso-quinoline. Exp. Toxicol. Pathol. 45: 473–479.

18.

18. Larson JL , Pino MV , Geiger LE , and Simeone CR (1996). The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats. Pharmacol. Toxicol. 78: 44–49.

19.

19. Lehman TJA , Allen JB , Plotz PH , and Wilder RL (1983). Polyarthritis in rats following the systemic injection of Lactobacillus casei cell wall in aqueous suspension. Arthritis Rheum. 26: 1259–1265.

20.

20. Mielens ZE and Rozitis J Jr (1964). Acute peri-articular inflammation induced in rats by oral 6-sulfanilylindazole. Proc. Soc. Exp. Biol. Med. 117: 751–754.

21.

21. Miller ML , Samuelson CO , and Ward JR (1978). Hematologic and serologic studies in 6-sulfanilamidoindazole arthritis. Arthritis Rheum. 21: 681–389.

22.

22. Miller ML , Ward FR , Cole BC , and Swinyard EA (1970). 6-Sulfanilamidoindazole induced arthritis and periarthritis in rats. A new model of experimental inflammation. Arthritis Rheum. 13: 222–235.

23.

23. Qasim FJ , Mathieson PW , Thiru S , and Oliveira DBG (1995). Cyclosporin A exacerbates mercuric chloride-induced vasculitis in the Brown Norway rat. Lab. Invest. 72: 183–190.

24.

24. Ribeiro MO , Antunes E , Nucci G , Lovisolo SM , and Zats R (1992). Chronic inhibition of nitric oxide synthesis. Hypertension 20: 298–303.

25.

25. Samuelson CO Jr , Griffiths MM , Mathews JL , Clegg DO , and Ward JR (1984). Susceptibility and resistance to 6-sulfanilamidoindazole-induced arthritis among inbred strains of rats. Arthritis Rheum. 27: 689–693.

26.

26. Sigg EB , Graeme ML , and John M (1967). Induction of periarthritis by oral administration of 6-sulfanilamidoindazole and its treatment in rats. J. Pharmacol. Exp. Ther. 157: 214–219.

27.

27. Suzuki T , Oboshi S , and Sato R (1979). Periarteritis nodosa in spontaneously hypertensive rats–Morphology of the arterial lesions with special reference to the initial changes. Acta Pathol. Jpn. 29: 853–864.

28.

28. Takeshita M , Hinoue H , Furukawa O , and Takata I (1994). Histo-pathological study of arthritic lesions induced by immunization with type II collagen in Lewis rats. Exp. Anim. 43: 105–109.

29.

29. Vingsbo C , Sahlstrand P , Brun JG , Jonsson R , Saxne T , and Holmdahl R (1996). Pristane-induced arthritis in rats. Am. J. Pathol. 149: 1675–1683.

30.

30. Westwood FR , Iswaran TJ , and Greaves P (1990). Pathologic changes in blood vessels following administration of an inotropic vasodilator (ICI 153,110) to the rat. Fundam. Appl. Toxicol. 14: 797–809.

31.

31. Yuhas EM , Morgan DG , Arena E , Kupp RP , Saunders LZ , and Lewis HB (1985). Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator. Am. J. Pathol. 119: 83–91.